WebDisclosure WebDisclosure
Basculer en Français
10900 Companies
237550 Keywords
166484 Articles
127594 Press releases
Headlines Articles Press releases InfuTronix Remove
  1. Home
  2. Companies
  3. InfuTronix
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/20/2024 at 14:05, 2 years 5 months ago

    InfuTronix Announces Voluntary Recall of Nimbus Ambulatory Infusion Pump System

    Patient Safety Medical Device Recall InfuTronix Recall Nimbus Ambulatory Infusion Pump FDA Re-clearance
  • BRIEF

    published on 03/20/2024 at 14:05, 2 years 5 months ago

    InfuTronix annonce le rappel volontaire du système de pompe à perfusion ambulatoire Nimbus

    Sécurité Du Patient Rappel De Dispositifs Médicaux Rappel D'InfuTronix Pompe À Perfusion Ambulatoire Nimbus Ré-autorisation FDA
  • PRESS RELEASE

    published on 03/20/2024 at 14:00, 2 years 5 months ago

    Voluntary Removal Announcement for the InfuTronix Nimbus Ambulatory Infusion Pump System

    InfuTronix, LLC announces voluntary recall of Nimbus Ambulatory Infusion Pump System from US Market due to identified product issues. System redesign planned for improvements
    InfuTronix Nimbus Infusion Pump Voluntary Recall Product Issues System Redesign
    Logo of InfuTronix
Accesswire
  • Published on 08/31/2026 at 15:50, 46 minutes ago

    Sarama Resources - Grant of Equity Incentives

  • Published on 08/31/2026 at 15:00, 1 hour 36 minutes ago

    Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available

  • Published on 08/31/2026 at 14:30, 2 hours 6 minutes ago

    Boron One Holdings Inc. Project Update

  • Published on 08/31/2026 at 14:30, 2 hours 6 minutes ago

    While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles

  • Published on 08/31/2026 at 13:30, 3 hours 6 minutes ago

    Nextech3D.ai Delivers 101% Revenue Growth in Fiscal Q1 2027 as AI-Powered Event Platform Accelerates

View all ACCESSWIRE
EQS Group
  • Published on 08/31/2026 at 16:09, 27 minutes ago

    Mayr-Melnhof Karton AG: MM Group secures EcoVadis Platinum, ranking among global top 1 % for sustainability

  • Published on 08/31/2026 at 15:40, 56 minutes ago

    EQS-Adhoc: SCP Standard Capital Partners AG expects to realize a book gain of approximately EUR 35 million from the acquisition of VANEA Technologies GmbH and Nocturne Technologies GmbH

  • Published on 08/31/2026 at 15:10, 1 hour 26 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 08/31/2026 at 15:09, 1 hour 27 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 08/31/2026 at 15:08, 1 hour 28 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS
Les Echos
  • Published on 08/31/2026 at 15:00, 1 hour 36 minutes ago

    Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital

  • Published on 08/31/2026 at 12:00, 4 hours 36 minutes ago

    Capital increase through exercise of subscription rights

  • Published on 08/31/2026 at 12:00, 4 hours 36 minutes ago

    Kapitaalverhoging door uitoefening van inschrijvingsrechten

  • Published on 08/31/2026 at 07:00, 9 hours 36 minutes ago

    Biophytis strengthens its financial position and extends its cash runway into Q1 2027

  • Published on 08/31/2026 at 07:00, 9 hours 36 minutes ago

    Biophytis renforce sa situation financière et étend son horizon de trésorerie au T1 2027

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy